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Improving the quality of health care has been a pre-
occupation since antiquity, one of the first recorded in-
stances being found in the Babylonian Hammurabi code
approximately 4000 years ago. Progressively, more stones
were added to the edifice of quality in health care: the
development of the experimental method, and the search
for causes of diseases and for effective remedies. In addi-
tion, more specific interventions to improve quality of
care were progressively introduced, such as the regulation
of training and licensing of health professions and the
accreditation (or other regulation) of hospitals and health
care organizations. Indeed, those attempts to improve
quality of care were developed with a public healtii per-
spective in mind. Other developments, often directly
imported from die pre-existing tools and processes used
in industry and service sectors, have occurred in recent
decades, fostered by die rapid changes in most health care
systems, die numerous health care technologies available
and increasing health care costs.
Clinical practice guidelines, clinical or critical pathways
or protocols constitute one set of instruments aimed at
improving die process and outcome of health care. Guide-
lines are fashionable; they have often been looked at
positively or even with enthusiasm by health care admin-
istrators, managers, health plan directors and health care
decision and policy makers.1 However, they have also
often been criticized by many, including clinicians, who
have seen them as an initiative to decrease independence
and professionalism, but also because of the uncertainty
regarding the effectiveness of guidelines to improve
quality of care eventually.1
QUALITY OF CARE AND GUIDELINES
Although it is widely acknowledged that it is difficult to
define quality of care, certain elements are common,
explicitly or implicitly, to many definitions of quality of
care. First, the indication to perform a medical procedure
or intervention - diagnostic, prognostic, therapeutic or
preventive - should be justified or appropriate, meaning
that the expected positive outcomes of the intervention
(i.e. its effectiveness) should significantly outweigh its
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possible negative effects. Second, when the decision to
perform the intervention has been made by the patient
and the physician, the proficiency of the care provider
should be guaranteed. This could mean, for instance, that
the team involved in the whole process of a surgical
operation should be properly trained and experienced or
that effective measures are taken to obtain an optimal
adherence to the treatment. Third, care must be delivered
with proper respect for interpersonal relationships be-
tween health carer professionals and patients, with hu-
manity and empathy, while preserving patient autonomy.
Fourth, equity of access to and delivery of quality care
should be guaranteed for all members of a population,
within the limits of available resources.
Clinical practice guidelines have been defined as 'system-
atically developed statements to assist practitioner and
patient decisions about appropriate health care for
specific clinical circumstances'.2 Guidelines are proposed
by many groups and authorities at the international,
national, regional or local level. Approximately 6,000
published articles have been indexed as guidelines (pub-
lication type) in the Medline database and there are many
more that are either not indexed or unpublished. Guide-
lines should help improve or maintain the four aspects of
health care mentioned in the previous paragraph (appro-
priateness, proficiency, humaneness and equity).
OVERUSE AND UNDERUSE OF MEDICAL CARE
According to the aforementioned definitions, overuse of
care is present when an intervention is proposed for an
inappropriate indication (i.e. the expected benefit of the
intervention is not significantly higher than its possible
negative effects). Guidelines are being advocated as a tool
to improve quality of care, by helping to reduce overuse
of care. However, in an era of cost containment and of
rapid and profound change in most health care systems,
guidelines are also being promoted with the idea of de-
creasing costs by diminishing inappropriate care.
This idea is often put forward without considering the
other side of the coin, underuse of care. Underuse has
been defined as the non-provision of crucial or necessary
care, the latter being defined as care that is not only
appropriate, but care that it would be negligent not to
propose to the patient in a particular situation.-3 Underuse
of care can be observed in population subgroups who have
no or only difficult access to health services, in patients
who do not use health services even though they have
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access to them and in patients occasionally or regularly in
contact with a physician. This is a well-known issue in
preventive medicine, but has also been reported in dia-
gnostic and therapeutic care. In addition, the coexistence
of under- and overuse of care in the same patient popula-
tion has been observed in various health care systems. For
instance, based on an observational study of the utiliza-
tion pattern of upper gastrointestinal endoscopy in over
8,000 patient visits in ambulatory care practice, it was
estimated that there was approximately the same number
of cases of overuse as there was of underuse of this dia-
gnostic procedure.4*5
This example illustrates that, if guidelines concerning the
appropriate use of upper gastrointestinal endoscopy were
to be implemented and generally followed, the crude
output could be an improvement in the quality of care
delivered because of the simultaneous decrease in both
under- and overuse of the procedure, but with no change
in the total number of endoscopies performed and, per-
haps, actually an increase in short-term costs, if we con-
sider the additional resources required to implement a
screening programme to detect over- and underuse. Vari-
ous hypotheses might be proposed for the impact on mid-
or long-term costs, depending, for instance, on the effect
of reducing underuse of (early) diagnostic and therapeutic
interventions on the discovery and effective treatment of
curable disease.
Among the other possible effects of broad implementa-
tion of guidelines, assuming that the guidelines will be
made available to the population at large, there could be
an increase in the awareness of the population of the need
for using health services and, therefore, more frequent
requests for the procedures available. Furthermore, in the
grey zone between over- and undemse, physicians accus-
tomed to proposing (costly) medical interventions with
discretion may feel pushed by guidelines to use them more
often in a defensive medicine era.6 On the odier hand,
excessively rigid adherence to guidelines may lead to
denial of access to procedures to patients who, because of
their unusual situations, may actually benefit from them,
with the net result being an increase in the undemse of
an effective procedure.
CLINICAL PRACTICE GUIDELINES
There are some indications that valid and carefully im-
plemented guidelines may indeed improve the quality of
care.7 However, as indicated previously, there might be
no accompanying cost saving. Furthermore, much effort
is spent in the development of thousands of guidelines at
various levels, from the international association to die
local hospital and, for many of them, there are doubts
about their quality and validity. Building on existing
developments, die promotion of a concerted inter-
national — or European — action could create and improve
a programme of valid and continuously updated guide-
lines aimed at covering the salient aspects of medical care.
In fact, a European concerted action is currently involved
in the process of developing a common appraisal instru-
ment for guidelines,8 which has been based on previous
work conducted in the UK.9 It may eventually turn out
that guideline developers will use the European appraisal
instrument as a guide for guidelines development.
If valid guidelines could be produced at a supranational
level, the effort at the national, regional and local levels
could then be concentrated on adapting, adopting, diffus-
ing and implementing the guidelines for the end users
(physicians, nurses, patients, etc.). It is indeed acknow-
ledged that guideline implementation, which is a crucial
step towards success, is all too often neglected.
Guidelines are considered as possible tools for imple-
menting evidence-based medicine. Ideally, evidence
should be derived from high-quality studies. For most
questions, such information does not exist and we have
to rely on other methods to produce valid guidelines.
When developed following a rigorous methodology, con-
sensus and other expert based development methods can
produce good quality guidelines.10 Using one particular
method (RAND appropriateness method) two European,
multinational, multidisciplinary expert panels have re-
cendy succeeded in developing explicit appropriateness
criteria for the use of upper and lower intestinal endoscopy
(Lausanne, Switzerland, November 1998) and coronary
revascularization (Madrid, Spain, December 1998).
These criteria will form a basis for the development of
practice guidelines. How these guidelines, developed at
the European level, will be received, accepted, adapted
and adopted in various European countries is still un-
known.
An initiative aimed at developing high-quality, Europe-
wide guidelines is attractive, but will certainly be an idea
difficult to promote and a development programme prob-
lematic to implement. However, the rapid development
of the Cochrane Collaboration might be cited here for
two reasons: first, it is an example of an active and
productive international collaboration and, second, its
products, the systematic reviews and the databases of
clinical trials and studies, are necessary ingredients for the
development of high-quality, evidence-based guidelines.
Indeed, high quality evidence should ignore borders.
However, variations in practice, health care organizations
and availability and the relative costs of medical proce-
dures and products within European countries are definite
sources of difficulty in developing common guidelines.
Variations in models of care as well as in medical and
general culture constitute additional barriers to the devel-
opment of common European guidelines.
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CHILD HEALTH
The section on international child public health resulting
from the recent call for papers1 has been re-scheduled for
publication in the September 1999 issue. Papers which
have completed the review process in time will be in-
cluded in the section or if completed later will be included
in the next available issue.
DISSERTATION ABSTRACTS
The journal is pleased to consider for publication abstracts
of recent doctoral dissertations of public health relevance.
For consideration, please submit an abstract of no more
than 250 words, arranged under the headings Back-
ground, Methods, Results and Conclusions, together with
one copy of your dissertation (non-returnable). Please
submit your material to: The Editors, European Journal of
Public Health, Karlstad University, Centre for Public
Health Research, SE-651 88 Karlstad, Sweden. This is
also the address to which other submissions and enquiries
should be sent.
NEW TECHNOLOGY
The journal is pleased to receive your confidential re-
viewer reports by e-mail. It is now possible to retrieve an
electronic version of the reviewer report form from
<ejph@kau.se> Please put the text 'Reviewer form re-
quest' in the subject line of your e-mail message.
REVISED CONTACT INFORMATION
Please update the contact information you have on file
for the journal, as the postal and e-mail addresses and
telephone and fax numbers have all been revised.
• The postal address for submissions and enquiries is given
above.
• The revised e-mail address is <ejph@kau.se>
The previous e-mail address has been removed from
service, and mail sent to it will not be automatically
forwarded.
• The telephone numbers are +46 54 700 2539 (direct
line) or +46 54 700 1000 (switchboard).
. The new fax number is +46 54 700 2530.
• For the very latest information concerning the journal,
please visit die EJPH web site at
<http://www.oup.co.uk/eurpub/>
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